
1. plos one. 2012;7(2):e31012. doi: 10.1371/journal.pone.0031012. epub 2012 feb 21.

an n-ethyl-n-nitrosourea (enu)-induced dominant negative mutation jak3
kinase protects cerebral malaria.

bongfen se(1), rodrigue-gervais ig, berghout j, torre s, cingolani p, wiltshire
sa, leiva-torres ga, letourneau l, sladek r, blanchette m, lathrop m, behr ma,
gruenheid s, vidal sm, saleh m, gros p.

author information: 
(1)department biochemistry, mcgill university, montreal, canada.

cerebral malaria (cm) lethal neurological complication malaria. we
implemented genome-wide screen mutagenized mice identify host proteins
involved cm pathogenesis whose inhibition may therapeutic value. one
pedigree (p48) segregated resistance trait whose cm-protective effect fully
penetrant, mapped chromosome 8, identified genome sequencing as
homozygosity mis-sense mutation (w81r) ferm domain of
janus-associated kinase 3 (jak3). causative effect jak3(w81r) verified
by complementation testing jak3(w81r/-) double heterozygotes fully
protected cm. jak3(w81r) homozygotes showed defects thymic development
with depletion cd8(+) cell, b cell, nk cell compartments, defective 
t cell-dependent production ifn-γ. adoptive transfer normal splenocytes
abrogates cm resistance jak3(w81r) homozygotes, effect attributed the
cd8(+) cells. jak3(w81r) behaves dominant negative variant, with
significant cm resistance jak3(w81r/+) heterozygotes, compared to
cm-susceptible jak3(+/+) jak3(+/-) controls. cm resistance jak3(w81r/+)
heterozygotes occurs presence normal t, b nk cell numbers. these
findings highlight pathological role cd8(+) cells jak3-dependent
ifn-γ-mediated th1 responses cm pathogenesis.

doi: 10.1371/journal.pone.0031012 
pmcid: pmc3283600
pmid: 22363534  [indexed medline]

